Chemical inhibitors of UEV3 function by disrupting the signaling pathways that are essential for its activation and stabilization. For instance, Triciribine and Perifosine act as inhibitors targeting the Akt phosphorylation process, which is a critical step for the activation of UEV3. Triciribine, a nucleoside analog, selectively inhibits the phosphorylation of Akt, thereby preventing the activation of UEV3 that is dependent on Akt's role in its pathway. Likewise, Perifosine obstructs Akt phosphorylation, leading to a decrease in UEV3 activity due to the deficient signaling necessary for its function. Similarly, MK-2206, GSK690693, GSK2110183, AT7867, ARQ 092, and AZD5363 are all Akt inhibitors that work through various mechanisms to prevent Akt from fulfilling its role in the UEV3 activation process. MK-2206 is an allosteric inhibitor, while GSK690693 is an ATP-competitive inhibitor, both resulting in the inhibition of Akt activity and consequently the functional inhibition of UEV3. GSK2110183 and ARQ 092 target Akt more directly, which leads to a subsequent decrease in UEV3 activity. AT7867's dual inhibition of both Akt and p70 S6 Kinase also results in reduced UEV3 activity due to the inhibition of the associated signaling cascade.
Further inhibiting the pathway upstream of UEV3, LY294002 and Wortmannin target PI3K, which is responsible for initiating the Akt signaling pathway. By inhibiting PI3K, LY294002 and Wortmannin limit Akt activation, which in turn restricts the activation of UEV3. Miltefosine, another PI3K inhibitor, similarly prevents the activation of Akt and therefore UEV3. Palomid 529 extends the inhibition to the broader PI3K/Akt/mTOR pathway, leading to a comprehensive downregulation of the signaling required for UEV3 activity. Each of these chemicals operates by inhibiting specific components of the signaling pathway that are upstream of UEV3, leading to a decrease in its activity by preventing the receipt of activating signals or by destabilizing the protein through the absence of its requisite signaling environment.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $102.00 $138.00 | 14 | |
Triciribine, a nucleoside analog, selectively inhibits Akt phosphorylation. UEV3, as part of the Akt pathway, would be functionally inhibited by the reduction in Akt activation, as it relies on Akt signaling for its role in the pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a potent inhibitor of PI3K, which is upstream of Akt. By inhibiting PI3K, LY294002 would reduce Akt activity and thereby functionally inhibit UEV3 by preventing its activation or stabilization within the PI3K/Akt pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is another PI3K inhibitor that would lead to decreased Akt activity. The inhibition of PI3K/Akt signaling would lead to functional inhibition of UEV3 since its activity is contingent on the proper functioning of this pathway. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $178.00 $325.00 | 67 | |
MK-2206 is an allosteric inhibitor of Akt. By inhibiting Akt, MK-2206 would functionally inhibit UEV3 as it acts downstream of Akt signaling, necessitating Akt activity for its function. | ||||||
GSK 690693 | 937174-76-0 | sc-363280 sc-363280A | 10 mg 50 mg | $255.00 $1071.00 | 4 | |
GSK690693 is an ATP-competitive inhibitor of Akt. This inhibition of Akt would prevent the activation of downstream proteins, including UEV3, thereby functionally inhibiting UEV3 activity. | ||||||
Miltefosine | 58066-85-6 | sc-203135 | 50 mg | $79.00 | 8 | |
Miltefosine is a PI3K inhibitor that would impair Akt activation. By inhibiting this pathway, Miltefosine functionally inhibits UEV3 by preventing the necessary signaling for its activity. | ||||||
Perifosine | 157716-52-4 | sc-364571 sc-364571A | 5 mg 10 mg | $184.00 $321.00 | 1 | |
Perifosine inhibits Akt phosphorylation and activation. This would lead to functional inhibition of UEV3 by reducing the signaling required for its activity within the Akt pathway. | ||||||
Palomid 529 | 914913-88-5 | sc-364563 sc-364563A | 10 mg 50 mg | $300.00 $1000.00 | ||
Palomid 529 is a PI3K/Akt/mTOR inhibitor, and by inhibiting this signaling pathway, it would functionally inhibit UEV3 by limiting the necessary signals for its activation. | ||||||
AZD5363 | 1143532-39-1 | sc-503190 | 5 mg | $309.00 | ||
AZD5363 directly inhibits Akt. The inhibition of Akt would cause functional inhibition of UEV3, as it is a downstream effector in the Akt pathway. | ||||||